NASDAQ:OPNT - Opiant Pharmaceuticals Earnings Date, Estimates & History

+0.48 (+3.11 %)
(As of 09/19/2019 02:16 AM ET)
Today's Range
Now: $15.90
50-Day Range
MA: $13.97
52-Week Range
Now: $15.90
Volume22,900 shs
Average Volume20,734 shs
Market Capitalization$62.49 million
P/E RatioN/A
Dividend YieldN/A


Opiant Pharmaceuticals (NASDAQ:OPNT) Earnings History and Estimates Chart

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Opiant Pharmaceuticals (NASDAQ:OPNT) Earnings Estimates

2019 EPS Consensus Estimate: ($1.74)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20191($0.88)($0.88)($0.88)
Q2 20191($0.62)($0.62)($0.62)
Q3 20191($0.36)($0.36)($0.36)
Q4 20191$0.12$0.12$0.12

Opiant Pharmaceuticals (NASDAQ OPNT) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/8/2019Q2 2019($0.55)$0.31$0.31$3.91 million$6.78 millionN/A
5/9/20193/31/2019($0.88)($0.44)($0.44)$1.90 million$5.44 millionTranscript
3/21/20197/31/2018($0.08)($0.37)($0.37)$5.20 million$4.76 millionTranscript
11/7/2018Q3($0.11)($0.32)($0.32)$4.70 million$4.37 millionN/A
8/9/2018Q2 2018($1.07)($0.52)($0.52)$2.10 million$3.15 millionN/A
5/8/2018Q1 2018($0.29)($3.68)($3.68)$2.00 million$1.70 millionN/A
12/4/2017Q1 2018($1.19)($2.77)($2.77)$0.02 millionN/A
10/13/2017Q4 2017($0.87)($0.17)($0.17)$3.77 millionN/A
6/14/2017Q3 2017($0.82)($1.55)($1.55)$0.02 millionN/A
3/16/2017Q2 2017($0.85)$4.91$4.91$13.54 millionN/A
12/16/2016Q1 2017($1.14)($0.30)($0.30)$0.70 million$1.12 millionN/A
10/31/2016Q4 2016($0.52)($0.52)$0.10 million$0.31 millionN/A
6/8/2016Q3 2016$0.15$0.15$2.61 millionN/A
3/15/2016Q2 2016$1.52$1.52$6.86 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 9/19/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel